“…Modulation of detoxifying enzymes (CYPs) (Baur & Sinclair, 2006), inhibition of protein kinase C (PKC) (Subbaramaiah et al., 1998), BCL‐2 (Kalra et al., 2008), and cell cycle regulators (Reagan‐Shaw, Afaq, Aziz, & Ahmad, 2004) are other chemoprevention effects of RSV. Overall, a myriad of studies has shown that several signaling pathways and various RSV targets including CD95 (Gao et al., 2002; Wenzel, Soldo, Erbersdobler, & Somoza, 2005), NF‐κβ (Li et al., 2010), Wnt (Parekh, Motiwale, Naik, & Rao, 2011), SIRT‐1, and PI3K/AKt (Kucharczak, Simmons, Fan, & Gélinas, 2003) involved in RSV‐induced anticancer effects. Tumor infraction and angiogenesis suppression are strategies against cancer spreading.…”